HWAIF
Healwell AI Inc.
OTC Markets OTCQXUSDEQUITY
Healthcare
DELAYED
Last price
0.57
▲ 0.00 (0.53%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.56
Prev close
0.57
Day high
0.58
Day low
0.56
Volume
2.00K
Market cap
$190.58M
P/E (TTM)
—
52W range
0.39 – 1.23
Day trading desk
Gap from prior close
-1.23%
Prior close 0.57
VWAP
0.58
-1.72% from price
Relative volume
0.01×
Quiet session
Session range
3.57%
0.56 – 0.58
Position in range
50%
Mid range
ATR (14D)
0.05
8.22% of price
Prior day high
0.59
PDH
Prior day low
0.53
PDL
Bid / ask spread
—
Quote not published
Session volume
1.00K
Avg 121.27K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.60%
+3.0%
1M
+19.00%
+15.3%
3M
-8.51%
-11.6%
6M
+26.67%
+15.6%
YTD
-8.06%
-20.4%
1Y
-40.56%
-60.6%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HWAIF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
150.97M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 8, 26 | Dobranowski (Alexander Julian) Director of Issuer |
— | 16.39K | — | Direct |
| Jun 25, 26 | Gera (Sacha) Senior Officer of Issuer |
— | 35.21K | — | Direct |
| Jun 25, 26 | Gera (Sacha) Senior Officer of Issuer |
— | 105.63K | — | Direct |
| Jun 25, 26 | Lam, Anthony Senior Officer of Issuer |
— | 50.00K | — | Direct |
| Jun 25, 26 | Lam, Anthony Senior Officer of Issuer |
— | 50.00K | — | Direct |
| Apr 10, 26 | Lam, Anthony Senior Officer of Issuer |
— | 44.94K | — | Direct |
| Apr 10, 26 | Lam, Anthony Senior Officer of Issuer |
— | 44.94K | — | Direct |
| Apr 10, 26 | Porter (Bradley James) Senior Officer of Issuer |
— | 196.63K | — | Direct |
| Dec 15, 25 | Dobranowski (Alexander Julian) Director of Issuer |
BUY | 1.00K | $637 | Direct |
| Dec 1, 25 | Corbet (Blake) Senior Officer of Issuer |
— | 118.75K | — | Direct |
| Dec 1, 25 | Porter (Bradley James) Senior Officer of Issuer |
— | 196.63K | — | Direct |
| Nov 27, 25 | Dobranowski (Alexander Julian) Director of Issuer |
BUY | 2.00K | $1.34K | Direct |
| Nov 21, 25 | Dobranowski (Alexander Julian) Director of Issuer |
BUY | 1.53K | $1.06K | Direct |
| Nov 12, 25 | Dobranowski (Alexander Julian) Director of Issuer |
BUY | 994 | $844 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Corbet (Blake) |
Senior Officer of Issuer | 159.38K | Exercise of rights |
Dobranowski (Alexander Julian) |
Director of Issuer | 2.04M | Conversion or exchange |
Gera (Sacha) |
Senior Officer of Issuer | 35.21K | Exercise of rights |
Lam, Anthony |
Senior Officer of Issuer | 249.89K | Exercise of rights |
McCrae (Ian Richard) |
10% Security Holder of Issuer | — | Change in nature of ownership |
Porter (Bradley James) |
Senior Officer of Issuer | 393.26K | Exercise of rights |
Fundamentals
Market cap$190.58M
Enterprise value$217.73M
Revenue (TTM)$128.74M
Gross profit$71.56M
EBITDA$-19.04M
Net income$-22.89M
EPS (TTM)$-0.06
Free cash flow$-7.87M
Total cash$39.81M
Total debt$84.51M
Book value / share$0.29
Shares outstanding303.55M
Float167.93M
Short % of float—
Dividend yield—
Beta (5Y)-0.97
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book1.94
EV / revenue1.69
EV / EBITDA-11.44
Gross margin55.59%
Operating margin-18.76%
Profit margin-23.01%
Return on equity-16.60%
Return on assets-4.25%
Debt / equity64.38
Current ratio1.03
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $103.80M | $19.71M | $7.32M | $10.42M | +426.6% |
| Operating revenue | $103.80M | $19.71M | $7.32M | $10.42M | +426.6% |
| Cost of revenue | $46.51M | $8.89M | $6.06M | $6.71M | +423.3% |
| Gross profit | $57.29M | $10.82M | $1.26M | $3.71M | +429.4% |
| Research & development | $16.42M | $5.79M | $4.81M | $8.14M | +183.3% |
| Selling, general & admin | $53.49M | $29.40M | $13.26M | $12.88M | +81.9% |
| Total operating expense | $86.82M | $41.27M | $18.07M | $21.03M | +110.4% |
| Operating income | -$29.53M | -$30.45M | -$16.82M | -$17.32M | +3.0% |
| Net interest income | -$9.59M | -$1.83M | -$1.75M | -$634.00K | -425.0% |
| Pre-tax income | -$39.78M | -$25.03M | -$32.68M | -$17.08M | -58.9% |
| Tax provision | -$662.00K | -$1.07M | -$542.00K | $1.12M | +38.2% |
| Net income | -$47.11M | -$26.29M | -$31.60M | -$21.09M | -79.2% |
| Net income to common | -$47.11M | -$26.29M | -$31.60M | -$21.09M | -79.2% |
| Basic EPS | -0.19 | -0.19 | -0.55 | -0.42 | 0.0% |
| Diluted EPS | -0.19 | -0.19 | -0.55 | -0.42 | 0.0% |
| EBIT | -$30.19M | -$23.20M | -$31.10M | -$16.46M | -30.1% |
| EBITDA | -$13.28M | -$15.90M | -$27.76M | -$13.92M | +16.5% |
| Basic shares | 250.55M | 135.56M | 57.03M | 50.08M | +84.8% |
| Diluted shares | 250.55M | 135.56M | 57.03M | 50.08M | +84.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $18.63M | $9.41M | $19.16M | $1.41M | +98.0% |
| Cash & short-term investments | $18.63M | $9.68M | $19.29M | $1.80M | +92.5% |
| Accounts receivable | $21.29M | $5.97M | $1.14M | $5.82M | +256.6% |
| Total current assets | $64.67M | $18.33M | $22.76M | $8.61M | +252.9% |
| Property, plant & equipment | $5.08M | $4.92M | $3.73M | $10.44M | +3.4% |
| Goodwill & intangibles | $205.47M | $95.45M | $24.81M | $21.32M | +115.3% |
| Total assets | $284.99M | $125.53M | $53.70M | $45.63M | +127.0% |
| Total current liabilities | $70.77M | $23.32M | $9.42M | $19.39M | +203.5% |
| Current debt | $24.10M | $1.78M | $672.00K | $7.00M | +1,253.7% |
| Long-term debt | $56.37M | $14.24M | $14.98M | — | +295.8% |
| Total debt | $86.13M | $22.20M | $20.93M | $17.42M | +287.9% |
| Total liabilities | $161.04M | $51.86M | $32.23M | $32.13M | +210.5% |
| Retained earnings | -$151.95M | -$95.22M | -$69.25M | -$37.65M | -59.6% |
| Shareholder equity | $123.94M | $63.89M | $12.65M | $11.78M | +94.0% |
| Working capital | -$6.10M | -$4.99M | $13.34M | -$10.78M | -22.2% |
| Net tangible assets | -$81.52M | -$31.56M | -$12.16M | -$9.55M | -158.3% |
| Shares issued | 324.12M | 199.63M | 118.79M | 86.08M | +62.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$39.12M | -$27.48M | -$31.55M | -$20.97M | — | -42.4% |
| Depreciation & amortisation | $16.91M | $7.30M | $3.34M | $2.54M | — | +131.7% |
| Stock-based compensation | $12.99M | $7.14M | $3.26M | $4.83M | — | +82.0% |
| Change in working capital | -$17.18M | -$2.83M | $1.07M | $2.21M | — | -506.5% |
| Operating cash flow | -$19.42M | -$22.62M | -$10.80M | -$8.35M | — | +14.1% |
| Capital expenditure | -$4.47M | -$1.31M | -$66.00K | -$1.15M | — | -240.8% |
| Investing cash flow | -$69.84M | -$15.73M | $1.45M | -$1.17M | — | -344.0% |
| Share buybacks | — | -$625.00K | $0 | $0 | -$870.00K | — |
| Dividends paid | $0 | $0 | — | — | $0 | — |
| Financing cash flow | $95.50M | $28.60M | $27.09M | $3.78M | — | +233.9% |
| Free cash flow | -$23.89M | -$23.93M | -$10.86M | -$9.49M | — | +0.2% |
| End cash position | $18.63M | $9.41M | $19.16M | $1.41M | — | +98.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $32.96M | $33.21M | $32.22M | $30.35M | $33.25M | — | -0.7% |
| Operating revenue | $32.96M | $33.21M | $32.22M | $30.35M | $33.25M | — | -0.7% |
| Cost of revenue | $15.03M | $13.71M | $14.57M | $13.84M | $14.52M | — | +9.7% |
| Gross profit | $17.92M | $19.50M | $17.64M | $16.51M | $18.73M | — | -8.1% |
| Research & development | $5.21M | $5.67M | $4.30M | $4.89M | $5.77M | — | -8.1% |
| Selling, general & admin | $13.88M | $14.55M | $14.46M | $13.72M | $14.30M | — | -4.6% |
| Total operating expense | $24.11M | $25.31M | $21.05M | $25.10M | $26.36M | — | -4.8% |
| Operating income | -$6.18M | -$5.81M | -$3.41M | -$8.59M | -$7.64M | — | -6.4% |
| Net interest income | -$3.33M | -$2.83M | -$2.84M | -$3.77M | -$1.74M | — | -17.5% |
| Pre-tax income | $7.30M | -$6.69M | -$6.35M | -$15.89M | -$4.99M | — | +209.2% |
| Tax provision | $905.00K | $161.00K | $400.00K | $106.00K | -$925.00K | — | +462.1% |
| Net income | $6.40M | -$6.85M | -$1.39M | -$27.86M | -$4.18M | — | +193.4% |
| Net income to common | $6.40M | -$6.85M | -$1.39M | -$27.86M | -$4.18M | — | +193.4% |
| Basic EPS | 0.02 | -0.02 | — | -0.12 | -0.02 | -0.08 | +200.0% |
| Diluted EPS | 0.02 | -0.02 | — | -0.12 | -0.02 | -0.08 | +200.0% |
| EBIT | $10.66M | -$3.79M | -$3.76M | -$11.96M | -$3.18M | — | +381.1% |
| EBITDA | $15.67M | $1.30M | -$1.46M | -$5.47M | $3.39M | — | +1,105.2% |
| Basic shares | 300.48M | 294.36M | — | 237.82M | 264.87M | 171.91M | +2.1% |
| Diluted shares | 319.46M | 294.36M | — | 237.82M | 264.87M | 171.91M | +8.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $16.78M | $21.95M | $18.63M | $15.61M | $19.08M | -23.5% |
| Cash & short-term investments | $39.81M | $21.95M | $18.63M | $15.61M | $19.08M | +81.4% |
| Accounts receivable | $18.54M | $14.75M | $21.29M | $16.98M | $21.82M | +25.7% |
| Total current assets | $86.19M | $60.39M | $64.67M | $78.47M | $67.48M | +42.7% |
| Property, plant & equipment | $3.14M | $5.07M | $5.08M | $5.37M | $8.78M | -38.0% |
| Goodwill & intangibles | $202.01M | $203.13M | $205.47M | $215.62M | $246.36M | -0.5% |
| Total assets | $296.79M | $278.35M | $284.99M | $309.79M | $331.90M | +6.6% |
| Total current liabilities | $83.33M | $67.75M | $70.77M | $92.16M | $97.78M | +23.0% |
| Current debt | $27.19M | $26.23M | $24.10M | $23.63M | $29.98M | +3.7% |
| Long-term debt | $54.38M | $55.47M | $56.37M | $58.78M | $48.51M | -2.0% |
| Total debt | $84.51M | $86.73M | $86.13M | $88.49M | $89.00M | -2.6% |
| Total liabilities | $165.53M | $156.87M | $161.04M | $185.66M | $183.54M | +5.5% |
| Retained earnings | -$152.39M | -$158.79M | -$151.95M | -$150.56M | -$113.16M | +4.0% |
| Shareholder equity | $131.26M | $121.48M | $123.94M | $120.31M | $138.80M | +8.1% |
| Working capital | $2.85M | -$7.37M | -$6.10M | -$13.69M | -$30.29M | +138.7% |
| Net tangible assets | -$70.75M | -$81.65M | -$81.52M | -$95.31M | -$107.56M | +13.3% |
| Shares issued | 333.42M | 326.36M | 324.12M | 309.20M | 296.54M | +2.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $6.40M | -$6.85M | -$6.75M | -$14.20M | -$4.12M | +193.5% |
| Depreciation & amortisation | $5.01M | $5.09M | $2.30M | $6.21M | $6.57M | -1.6% |
| Stock-based compensation | $2.11M | $1.98M | $2.83M | $3.15M | $3.65M | +6.8% |
| Change in working capital | $1.03M | $4.63M | -$3.21M | -$9.31M | -$5.63M | -77.8% |
| Operating cash flow | -$447.00K | $4.94M | $672.00K | -$10.46M | -$5.60M | -109.0% |
| Capital expenditure | -$2.12M | -$1.35M | -$1.73M | -$1.31M | -$1.26M | -56.7% |
| Investing cash flow | -$2.12M | -$705.00K | $4.36M | -$610.00K | $13.21M | -200.7% |
| Financing cash flow | -$2.99M | -$812.00K | -$4.22M | $5.36M | -$5.39M | -268.3% |
| Free cash flow | -$2.57M | $3.59M | -$1.06M | -$11.77M | -$6.86M | -171.5% |
| End cash position | $16.78M | $21.95M | $18.63M | $15.61M | $19.08M | -23.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $33.20M | +9.4% |
| Next quarter | — | — | $36.36M | +12.9% |
| Current year | — | — | $135.73M | +30.8% |
| Next year | — | — | $154.32M | +13.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders49.73%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.54
+4.76% from price
SMA 20
0.51
+12.51% from price
SMA 50
0.53
+8.56% from price
SMA 100
0.58
-2.52% from price
SMA 200
0.61
-6.95% from price
EMA 12
0.54
+6.17% from price
EMA 26
0.52
+8.82% from price
EMA 50
0.54
+6.50% from price
RSI (14)
62.5
Neutral
MACD (12,26,9)
0.01
Hist 0.01
ATR (14)
0.05
8.22% of price
Realised vol 30D
67.2%
Annualised
Bollinger upper
0.59
20, 2σ
Bollinger lower
0.43
20, 2σ
50 / 200 cross
Death
0.53 vs 0.61
Trend bias
Below 200
-6.95%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.89
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
67.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-60.9%
Peak to trough
Max drawdown 5Y
-72.8%
Peak to trough
ATR 14
0.05
8.22% of price
Beta (reported)
-0.97
5Y monthly, from filing
SEC filings
Headlines
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
TMX Newsfile · 4d ago
HEALWELL Achieves Revenue of $33 Million, Improved Operating Cash Flow and a Strengthened Balance Sheet in Q2-2026
TMX Newsfile · 17d ago
HEALWELL AI Announces Conference Call for Second Quarter 2026 Financial Results on August 7, 2026
TMX Newsfile · 19d ago
Healwell AI (TSX:AIDX) Stock Fair Value Falls As Analysts Trim Growth Assumptions
Simply Wall St. · 58d ago
HEALWELL AI Announces Voting Results of 2026 AGSM
TMX Newsfile · 58d ago
HEALWELL AI Provides Corporate Update: Multi-Province AI Pilot Results Accepted at AMIA Symposium; Alongside Balance Sheet Strengthening with SpaceX Holdings
TMX Newsfile · 67d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.